205 related articles for article (PubMed ID: 29785018)
1. Pulmonary adenocarcinoma with high-grade fetal adenocarcinoma component has a poor prognosis, comparable to that of micropapillary adenocarcinoma.
Suzuki M; Nakatani Y; Ito H; Narimatsu H; Yamada K; Yoshioka E; Washimi K; Okubo Y; Kawachi K; Miyagi Y; Yokose T
Mod Pathol; 2018 Sep; 31(9):1404-1417. PubMed ID: 29785018
[TBL] [Abstract][Full Text] [Related]
2. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung.
Kim M; Chung YS; Kim KA; Shim HS
Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770
[TBL] [Abstract][Full Text] [Related]
4. Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.
Sun Y; Yu X; Shi X; Hong W; Zhao J; Shi L
World J Surg Oncol; 2014 May; 12():148. PubMed ID: 24885205
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.
Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S
Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients.
Yang F; Chen K; Liao Y; Li X; Sun K; Bao D; Wang J
World J Surg Oncol; 2014 Sep; 12():285. PubMed ID: 25216551
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2022 Sep; 13(17):2473-2479. PubMed ID: 35820717
[TBL] [Abstract][Full Text] [Related]
8. [Validation of prognostic value of pathological staging in pathological stage Ⅰ lung adenocarcinoma].
Zhang H; Sun FH; Chen ZC; Wang Q
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):580-586. PubMed ID: 35658346
[No Abstract] [Full Text] [Related]
9. High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study.
Talvitie EM; Vilhonen H; Kurki S; Karlsson A; Orte K; Almangush A; Mohamed H; Liljeroos L; Singh Y; Leivo I; Laitinen T; Kallajoki M; Taimen P
Neoplasia; 2020 Sep; 22(9):333-342. PubMed ID: 32585428
[TBL] [Abstract][Full Text] [Related]
10. The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinoma.
Hou Y; Song W; Chen M; Zhang J; Luo Q; Um SW; Facchinetti F; Bongiolatti S; Zhou Q
Transl Lung Cancer Res; 2022 Jan; 11(1):64-74. PubMed ID: 35242628
[TBL] [Abstract][Full Text] [Related]
11. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.
Yoshizawa A; Motoi N; Riely GJ; Sima CS; Gerald WL; Kris MG; Park BJ; Rusch VW; Travis WD
Mod Pathol; 2011 May; 24(5):653-64. PubMed ID: 21252858
[TBL] [Abstract][Full Text] [Related]
12. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
13. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database.
Bertoglio P; Querzoli G; Ventura L; Aprile V; Cattoni MA; Nachira D; Lococo F; Rodriguez Perez M; Guerrera F; Minervini F; Gnetti L; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Viti A; Bogina GS; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Ampollini L; Terzi AC
J Surg Oncol; 2021 Feb; 123(2):560-569. PubMed ID: 33169397
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological, Radiological, and Molecular Features of Primary Lung Adenocarcinoma with Morule-Like Components.
Wang LL; Ding L; Zhao P; Guan JJ; Ji XB; Zhou XL; Shao SH; Zou YW; Fu WW; Lin DL
Dis Markers; 2021; 2021():9186056. PubMed ID: 34234879
[TBL] [Abstract][Full Text] [Related]
16. Expansion of the Concept of Micropapillary Adenocarcinoma to Include a Newly Recognized Filigree Pattern as Well as the Classical Pattern Based on 1468 Stage I Lung Adenocarcinomas.
Emoto K; Eguchi T; Tan KS; Takahashi Y; Aly RG; Rekhtman N; Travis WD; Adusumilli PS
J Thorac Oncol; 2019 Nov; 14(11):1948-1961. PubMed ID: 31352072
[TBL] [Abstract][Full Text] [Related]
17. Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis.
Zhao Y; Wang R; Shen X; Pan Y; Cheng C; Li Y; Shen L; Zhang Y; Li H; Zheng D; Ye T; Zheng S; Sun Y; Chen H
Ann Surg Oncol; 2016 Jun; 23(6):2099-105. PubMed ID: 26842488
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of microscopic size in peripherally located scar-associated clinical stage I lung carcinomas.
Trejo Bittar HE; Jerome JA; Hartman D; Pantanowitz L; Mehrad M; Dacic S
Lung Cancer; 2020 May; 143():12-18. PubMed ID: 32200136
[TBL] [Abstract][Full Text] [Related]
19. High-grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high-grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases.
Suzuki M; Yazawa T; Ota S; Morimoto J; Yoshino I; Yamanaka S; Inayama Y; Kawabata Y; Shimizu Y; Komatsu M; Notohara K; Koda K; Nakatani Y
Histopathology; 2015 Dec; 67(6):806-16. PubMed ID: 25851923
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
